Hierarchically design MoS2/CdNi@RGO ultra-thin hybrid sheet for Photocatalytic degradation of organic contaminants fingerprinting in environmental matrices

Article

Author: Arumugam, Natarajan ; Senganiselvi, M ; Seethalakshmi, T

The aim of this study was to synthesize effective and economical MoS₂/CdNi@rGO photocatalysts and investigate their performance in the degradation of organic pollutants in synthetic effluent. The objective was to assess the characterization results of the synthesized photocatalysts using XRD, SEM/EDS, TEM/HR-TEM, Raman spectrum, and BET isotherm analysis tools. These analyses revealed the good adhesion of MoS₂ with rGO and provided insights into the structure and properties of the materials. The results showed that the MoS₂/CdNi@rGO photocatalysts exhibited remarkable degradation efficiency for organic pollutants such as Rhodamine-B, erichrome black, and malachite green. The outcomes of the study demonstrated that the MoS₂/CdNi@rGO catalyst had the greatest rate constant for Rhodamine-B (RhB) decomposition. which would have been approximately 33 times higher than that of pure RGO (0.0121 min^-1). The MoS₂/CdNi@rGO photocatalysts also showed excellent recyclability and persistence across five recycle assays, indicating their potential for practical applications in wastewater treatment. The photocatalyst was moderately active, stable up to its fifth usage and stability of the photocatalyst before and after the photocatalytic reaction was also been studied using XRD and SEM. Further research in this area could lead to the development of advanced photocatalytic technologies for environmental remediation.

29 Oct 2024·Environmental Science & Technology

Behavioral Responses of Chironomus aprilinus Larvae as Proxies for Cyanobacterial Metabolite Interactions: Insights from Ternary Combinations

Article

Author: Bownik, Adam ; Pawlik-Skowrońska, Barbara ; Wlodkowic, Donald ; Mieczan, Tomasz

This study aimed to assess the behavioral responses (immobilization, horizontal and vertical motility, and response to light) of Chironomus aprilinus larvae exposed to individual cyanobacterial metabolites aeruginosin 98B (AER-B), anabaenopeptin-B (ANA-B), and cylindrospermopsin (CYL), and their binary and ternary mixtures. The investigation revealed that single metabolites ANA-B and CYL exhibited the highest potency in immobilizing the larvae. Notably, the binary mixture AER-B+CYL induced a remarkably strong synergistic interaction, while other tested binary and ternary mixtures demonstrated antagonistic effects. Both individual metabolites and their mixtures led to a decrease in larval movement speed, with the AER-B+CYL combination showing a very synergistic effect, and strong antagonistic interactions between the oligopeptides in the ternary mixture. Conversely, while AER-B and the binary mixture ANA-B+CYL stimulated vertical movement, other single metabolites and binary and ternary mixtures decreased this parameter. Antagonistic interactions were observed in all mixtures. ANA-B emerged as the most potent inhibitor, yet all tested metabolites and their mixtures decreased larval response to light, displaying synergistic interactions, except for the AER-B+ANA-B mixture at 250 μg L^-1 + 250 μg L^-1. These findings underscore the sensitivity of Chironomus larvae behavioral parameters as indicators of environmental stressors and mixtures. Consequently, they are recommended for assessing toxic effects induced by cyanobacterial products and other bioactive chemicals.

01 Oct 2024·International Journal of Pharmaceutics

Optimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages

Article

Author: Greene, Michelle K ; Alsa'd, Alhareth A ; Tayyem, May ; Gilmore, Brendan F ; Elmore, Bronagh ; Scott, Christopher J ; Abed, Anas ; Burden, Roberta E ; Burrows, James F

Bacteria can evade antimicrobial therapy by hiding inside host cells such as macrophages. Here we examine the ability of PLGA nanoparticles to deliver antibiotics to intracellular bacteria, specifically focusing upon the impact of nanoparticle size. Different sized Rhodamine-B conjugated PLGA nanoparticles were synthesized and uptake examined in two macrophage cell lines, as well as different epithelial cells, to determine the optimal properties for macrophage uptake. These studies demonstrate macrophages display a consistent increase in uptake with increased PLGA nanoparticle diameter. In a bacteria-macrophage co-culture model, we then examined the efficacy of different sized antibiotic-loaded PLGA nanoparticles against intracellular infections with K. pneumoniae and S. aureus. Increasing the size of antibiotic-loaded PLGA nanoparticles significantly increased their potency against intracellular K. pneumoniae. However, this was not observed for S. aureus, potentially due to the observation these nanoparticles failed to access the compartment in which S. aureus reside. This work demonstrates for the first time that increasing the size of antibiotic-loaded PLGA nanoparticles can significantly enhance antimicrobial efficacy against K. pneumoniae intracellular macrophage infections. However, our S. aureus studies indicate this is not a 'one size fits all' approach for all intracellular infections.

100 Deals associated with MEN-B

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Meningitis	Preclinical	US	Xenova Biomedix Ltd	22 May 2023

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

MEN-B

Overview

Basic Info

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation